Total Funding
59
23
Total FundingSeed raised
Growth Score 59 in past quarter
-3 pts
Heat Score 23 in past quarter
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
124144
Stimunity is an early-stage research and development company focused on the development of STING agonists in cancer.
- Sylvain Carlioz: Co-Founder & CEOPast Role: Xerium Technologies, R&D Engineer
- Nicolas Manel: Scientific Advisor & Founder
About the Company
Stimunity is a preclinical-stage startup company which develops best-in-class drugs on the STING pathway to activate the innate immune system. Their drugs stimulate patients' immune system to fight back infectious pathogens or cancer.